Given the nature of the decisions to be made, including around providing or withdrawing life-sustaining treatment, the stakes can be high - and so too can the emotions of those involved.
Richard Huxtable
<p>Richard Huxtable is professor of medical ethics and law at the University of Bristol, where he directs the <a href=\"http://www.bristol.ac.uk/population-health-sciences/centres/ethics/\" target=\"_blank\">Centre for Ethics in Medicine</a>, in the Medical School. His research concerns end-of-life decision-making, surgical ethics, and clinical ethics. His eight books include <a href=\"https://www.routledge.com/Law-Ethics-and-Compromise-at-the-Limits-of-Life-To-Treat-or-not-to-Treat/Huxtable/p/book/9780415492805\" target=\"_blank\">Law, Ethics and Compromise at the Limits of Life: To Treat or Not to Treat?</a> (Routledge, 2012) and he leads the Wellcome Trust collaborative project, <a href=\"http://www.bristol.ac.uk/population-health-sciences/centres/ethics/research/babel/\" target=\"_blank\">Balancing Best Interests in Healthcare, Ethics and Law</a> (BABEL).</p><p>Richard has served on various ethics committees, including those of the BMA and the RCGP, and he chairs the <a href=\"http://www.ukcen.net/\" target=\"_blank\">UK Clinical Ethics Network</a>. </p><p>Twitter: <a href=\"https://twitter.com/ProfRHuxtable\" target=\"_blank\">@ProfRHuxtable</a></p>
Harleen Johal
Harleen Kaur Johal is a junior doctor and PhD candidate in the Centre for Ethics in Medicine at the University of Bristol. Her research explores <a href=\"http://www.bristol.ac.uk/critical-study\" target=\"_blank\">conflict resolution in the adult intensive care unit</a>, specifically focusing on disagreements that arise in ‘best interests' decision making.</p><p style=\"margin: 12pt 0cm;\">Her PhD is supported by the Wellcome Trust as part of the <a href=\"http://www.bristol.ac.uk/population-health-sciences/centres/ethics/research/babel/\" target=\"_blank\">Balancing Best Interests in Healthcare, Ethics and Law</a> (BABEL) project. Harleen has worked in intensive care and with local and regional clinical ethics advisory groups, during the COVID-19 pandemic.</p><p>Twitter: <a href=\"https://twitter.com/harleen_johal\" target=\"_blank\">@harleen_johal</a></p>